Stocks & Investing
Mon, April 29, 2024
Tue, March 5, 2024
[ 12:00 AM ] - WOPRAI
Wed, January 3, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 15, 2023
[ 12:00 AM ] - WOPRAI
Tue, August 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, July 14, 2023
Wed, March 29, 2023
[ 12:00 AM ] - WOPRAI
Mon, October 10, 2022
Fri, September 16, 2022
[ 12:00 AM ] - WOPRAI
Thu, February 11, 2021
[ 12:00 AM ] - WOPRAI
Mon, October 19, 2020
[ 12:00 AM ] - WOPRAI
Tue, March 13, 2018
[ 12:00 AM ] - WOPRAI
Tue, February 6, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, October 23, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, July 28, 2017
[ 12:00 AM ] - WOPRAI
Thu, July 27, 2017
Fri, December 9, 2016
Mon, May 2, 2016
[ 12:00 AM ] - WOPRAI
Wed, December 2, 2015
Mon, July 27, 2015
[ 12:00 AM ] - WOPRAI
Thu, March 12, 2015
[ 12:00 AM ] - WOPRAI
Thu, January 22, 2015
[ 12:00 AM ] - WOPRAI
Thu, October 2, 2014
[ 12:00 AM ] - WOPRAI
Thu, May 15, 2014
[ 12:00 AM ] - WOPRAI
Thu, May 16, 2013
Thu, August 2, 2012 Seamus Fernandez Downgraded (ALT) to Hold on, Apr 29th, 2024
Seamus Fernandez of Guggenheim, Downgraded "Altimmune, Inc." (ALT) to Hold on, Apr 29th, 2024.
Seamus has made no other calls on ALT in the last 4 months.
There are 3 other peers that have a rating on ALT. Out of the 3 peers that are also analyzing ALT, 1 agrees with Seamus's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Corinne Jenkins of "Goldman Sachs" Initiated at Hold and Held Target at $13 on, Wednesday, January 24th, 2024
These are the ratings of the 2 analyists that currently disagree with Seamus
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $12 on, Monday, April 1st, 2024
- Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024
